No evidence for sex differences in the severity and treatment of cancer pain

Journal of Pain and Symptom Management

Volumn 28, Issue 3, 2004, Pages 225-232

  Edrington, Janet M ^a   Paul, Steven ^a   Dodd, Marylin ^a   West, Claudia ^a   Facione, Noreen ^a   Tripathy, Debu ^a   Koo, Peter ^a   Schumacher, Karen ^a   Miaskowski, Christine ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cancer pain; cancer pain management; chronic pain; Gender differences; sex differences

Indexed keywords

ANALGESIC AGENT; MORPHINE; OPIATE;

ADULT; ARTICLE; BONE METASTASIS; CANCER PAIN; CLINICAL TRIAL; DISEASE SEVERITY; DOSE RESPONSE; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PAIN ASSESSMENT; PRESCRIPTION; SEX DIFFERENCE; SEXUAL BEHAVIOR; STATISTICAL SIGNIFICANCE;

AGED; ANALGESICS; BONE NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 4344616284     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2003.12.013     Document Type: Article

References (30)

1. Fillingim R., Maixner W. Gender differences in responses to noxious stimuli. Pain Forum. 4:1995;209-221
2. Fillingim R.B., Edwards R.R., Powell T. The relationship of sex and clinical pain to experimental pain responses. Pain. 83:1999;419-425
3. Fillingim R.B., Ness T.J. Sex-related hormonal influences on pain and analgesic responses. Neurosci Biobehav Rev. 24:2000;485-501
4. Riley J.L., Robinson M.E., Wise E.A., et al. Sex differences in the perception of noxious experimental stimuli: a meta-analysis. Pain. 74:1998;181-187
5. Unruh A.M. Gender variations in clinical pain experience. Pain. 65:1996;123-167
6. Le Resche L. Epidemiologic perspectives on sex differences in pain. Fillingim R.B. Sex, gender, and pain. Progress in pain research and management. vol. 17:2000;233-249 IASP Press, Seattle
7. Gear R.W., Gordon N.C., Heller P.H., et al. Gender difference in analgesic response to the kappa-opioid pentazocine. Neurosci Lett. 205:1996;207-209
8. Gear R.W., Miaskowski C., Gordon N.C., et al. Kappa-opioids produce significantly greater analgesia in women than in men. Nat Med. 2:1996;1248-1250
9. Gear R.W., Miaskowski C., Gordon N.C., et al. The kappa opioid nalbuphine produces gender- and dosedependent analgesia and antianalgesia in patients with postoperative pain. Pain. 83:1999;339-345
10. Gear R.W., Miaskowski C., Heller P.H., et al. Benzodiazepine mediated antagonism of opioid analgesia. Pain. 71:1999;25-29
11. Gear R.W., Gordon N.C., Miaskowski C., et al. Sexual dimorphism in very low dose nalbuphine postoperative analgesia. Neurosci Lett. 339:2003;1-4
12. Kest B., Sarton E., Dahan A. Gender differences in opioid-mediated analgesia: animal and human studies. Anesthesiology. 93:2000;539-547
13. Sarton E., Olofsen E., Romberg R., et al. Sex differences in morphine analgesia: an experimental study in healthy volunteers. Anesthesiology. 93:2000;1245-1254
14. Grond S., Zech D., Diefenbach C., et al. Prevalence and pattern of symptoms in patients with cancer pain: a prospective evaluation of 1635 cancer patients referred to a pain clinic. J Pain Symptom Manage. 9:1994;372-382
15. Cleeland C.S., Gonin R., Hatfield A.K., et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med. 330:1994;592-596
16. Turk D.C., Okifuji A. Does sex make a difference in the prescription of treatments and the adaptation to chronic pain by cancer and non-cancer patients? Pain. 82:1999;139-148
17. Melzack R. The short-form McGill Pain Questionnaire. Pain. 30:1987;191-197
18. Kerns R.D., Turk D.C., Rudy T.E. The West Haven-Yale Multidimensional Pain Inventory (WHYMPI). Pain. 23:1985;345-356
19. Miaskowski C., Dodd M.J., West C., et al. Lack of adherence with the analgesic regimen: a significant barrier to effective cancer pain management. J Clin Oncol. 19:2001;4275-4279
20. Schumacher K.L., Koresawa S., West C., et al. Putting cancer pain management regimens into practice at home. J Pain Symptom Manage. 23:2002;369-382
21. West C.M., Dodd M.J., Paul S.M., et al. The PRO-SELF(c) Pain Control Program: an effective approach for cancer pain management. Oncol Nurs Forum. 30:(1):2003;65-73
22. Karnofsy D. Performance scale. Mitchell M.S. Factors that influence the therapeutic response in cancer. 1977;29-37 Plenum Press, New York
23. Cleeland C.S. Measurement of pain by subjective report. Chapman C.R., Loeser J.D. Issues in pain measurement. Advances in pain research and therapy. vol. 12:1989;391-403 Raven Press, New York
24. Schumacher K.L., Koresawa S., West C., et al. The usefulness of a daily pain management diary for oncology outpatients with cancer-related pain. Oncol Nurs Forum. 29:(9):2002;1304-1313
25. Steedman S.M., Middaugh S.J., Kee W.G., et al. Chronic pain medications: equivalence levels and method of quantifying usage. Clin J Pain. 8:1992;204-214
26. Jacox A., Carr D.B., Payne R., et al. Management of cancer pain. Clinical Practice Guideline No. 9. AHCPR Publication No. 94-0592. 1994;Agency for Health Care Policy and Research, US Department of Health and Human Services, Public Health Service, Rockville, MD
27. Schover L.R., Fouladi R.T., Warneke C.L., et al. Defining sexual outcomes after treatment for localized prostate cancer. Cancer. 95:(8):2002;1773-1785
28. Penson D.F., Litwin M.S., Lubeck D.P., et al. Transitions in health-related quality of life during the first nine months after diagnosis with prostate cancer. Prostate Cancer Prostatic Dis. 1:(3):1998;134-143
29. Van Vulpen M., De Leeuw J.R., Van Gellekom M.P., et al. A prospective quality of life study in patients with locally advanced prostate cancer, treated with radiotherapy with or without regional or interstitial hyperthermia. Int J Hyperthermia. 19:(4):2003;402-413
30. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed:1988;Lawrence Erlbaum Associates, Hillsdale, NJ